January 31, 2022
Article
Primary and metastatic brain tumors present a significant therapeutic challenge, in large part because they are protected by the blood-brain barrier, a highly restrictive interface between the bloodstream and the brain that prevents most drugs from accessing the brain parenchyma.
January 28, 2022
Article
Oncology Live®
Treatment of patients with metastatic cervical cancer remains challenging—the 5-year overall survival rate is just 17%.
January 27, 2022
Article
Patients with cancer should be fully immunized against COVID-19, including third doses and/or any approved boosters.
January 26, 2022
Article
Debu Tripathy, MD, discusses key developments that may set the stage for new directions in care of breast cancer, including several areas of the treatment landscape on the cusp of change.
January 25, 2022
Article
Nathaniel Ivanick, MD, FCCP, explains advancements in the use of robotic navigational bronchoscopy for the diagnosis of early-stage lung cancer.
January 24, 2022
Article
Ajai Chari, MD, reviews the takeaways from the PLEIADES trial and its comparability with the CANDOR trial, and how a subcutaneous formulation of a daratumumab combination became a pivotal player in the treatment enhancement for patients with relapsed or refractory multiple myeloma.
January 20, 2022
Article
Maurie Markman, MD, discusses the debate between surrogate end points of overall survival and progression-free survival in clinical trials within oncology.